Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.19.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income/(Loss)
Accumulated Deficit
Balance (in shares) at Mar. 31, 2016   66,284,606 100,000 754,599      
Balance at Mar. 31, 2016 $ 82,271 $ 8 $ 100 $ (71) $ 295,423 $ (202) $ (212,987)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (24,264)           (24,264)
Foreign currency translation (119)         (119)  
Stock-based compensation (in shares)   331,363          
Stock-based compensation 3,748       3,748    
Stock-based compensation related to vesting of restricted stock for services (in shares)   0          
Stock-based compensation related to vesting of restricted stock for services 408       408    
Options exercised (in shares)   18,383          
Options exercised 11       11    
Shares cancelled (in shares)   (39,545)          
Shares cancelled (10)       (10)    
Balance (in shares) at Mar. 31, 2017   66,594,807 100,000 754,599      
Balance at Mar. 31, 2017 62,045 $ 8 $ 100 $ (71) 299,580 (321) (237,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (52,857)           (52,857)
Foreign currency translation (4)         (4)  
Warrants issued for services rendered 28       28    
Stock-based compensation (in shares)   265,138          
Stock-based compensation 3,138       3,138    
Stock-based compensation related to vesting of restricted stock for services (in shares)   100,000          
Stock-based compensation related to vesting of restricted stock for services 69       69    
Options exercised (in shares)   258,281          
Options exercised 269       269    
Exercise of warrants (in shares)   266,152          
Exercise of warrants 350       350    
Stock issued for settlement of liability (in shares)   8,624,445          
Stock issued for settlement of liability 14,634 $ 2     14,632    
Balance (in shares) at Mar. 31, 2018   76,108,823 100,000 754,599      
Balance at Mar. 31, 2018 27,672 $ 10 $ 100 $ (71) 318,066 (325) (290,108)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (6,010)           (6,010)
Foreign currency translation (31)         (31)  
Stock-based compensation (in shares)   306,656          
Stock-based compensation 2,568       2,568    
Options exercised (in shares)   424,817          
Options exercised 423       423    
Exercise of warrants (in shares)   333,924          
Exercise of warrants 1,154       1,154    
Stock issued for settlement of liability (in shares)   4,446,265          
Stock issued for settlement of liability 10,582       10,582    
Balance (in shares) at Mar. 31, 2019   81,620,485 100,000 754,599      
Balance at Mar. 31, 2019 $ 36,358 $ 10 $ 100 $ (71) $ 332,793 $ (356) $ (296,118)